A new clinical trial for those suffering from mesothelioma is set to begin at the Moffit Cancer Center in Tampa, Florida. Doctors and researchers at the center are anxious to launch the Mesothelioma Selective Chemoperfusion Study designed to serve patients who are not responding favorably to traditional mesothelioma treatment. Scientists are hopeful that this medical breakthrough will not only help mesothelioma suffers, but other cancer patients as well.
The new treatment method uses an X-ray test known as angiogram to help identify the blood vessels that provide oxygen and nutrients to cancerous tumors. When discovered, the blood vessels are overloaded with high doses of chemotherapy in hopes of slowing or stopping the growth of mesothelioma. In addition, targeting specific blood vessels prevent cancer treatment drugs from circulating throughout a patient’s entire body. This can significantly reduce the negative side-effects that people often experience as a result of standard chemotherapy treatments.
The procedure used since 2013 in Germany and Egypt has yielded positive results. Nearly half the number of patients who did not respond favorably to standard treatment achieved significantly better outcomes through chemoperfusion therapy. In 49 percent of the cases, the treatment halted growth or reduced the size of tumors. As a result, mesothelioma patients had an easier time breathing which improved the quality of their lives.
Mesothelioma sufferers selected for the clinical trial will be closely monitored during and after they receive four to eight weekly treatments. Although doctors and researchers are not claiming that cheomoperfusion therapy will cure their patients’ cancers, they are confident that the treatment can improve and prolong the quality of their lives.
A diagnosis of mesothelioma can be devastating for patients and their families. If you or a loved one has been exposed to asbestos or have been diagnosed with an asbestos-related illness, call Philadelphia mesothelioma lawyers of Brookman, Rosenberg, Brown & Sandler. Our offices are located in Center City Philadelphia and we serve clients throughout Philadelphia and New Jersey. Call our offices at 800-369-0899 or contact us online to discuss your case and ensure you receive the compensation to which you are entitled.
Mesothelioma is an aggressive cancer linked to asbestos exposure, yet public awareness about its causes and risks remains limited. Many…
Living in an apartment can be convenient, but it can also come with hidden dangers—like asbestos exposure. This mineral, once…
Asbestos is most often associated with construction and industrial settings, but landscaping professionals may also face hazards linked to asbestos…
Military personnel have been stationed in hazardous places for decades. Many years ago, military personnel were exposed to asbestos on the…
Asbestos was widely used in construction materials for decades, particularly before the late 1980s. Many schools across the United States…
Mesothelioma is a rare and aggressive cancer caused by asbestos exposure. Because it develops slowly and is difficult to diagnose…